Switching to E-cigarettes in Smokers Not Interested in Quitting
Public ClinicalTrials.gov record NCT05703672. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
4th Generation E-cigarettes: Reducing Harm and Quitting Combustible Cigarettes in Dual Users
Study identification
- NCT ID
- NCT05703672
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- University of Kansas Medical Center
- Other
- Enrollment
- 500 participants
Conditions and interventions
Conditions
Interventions
- Varenicline Tartrate Drug
- Placebo Drug
- Electronic cigarette Other
Drug · Other
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 16, 2023
- Primary completion
- Dec 6, 2026
- Completion
- Feb 27, 2027
- Last update posted
- Dec 28, 2025
2023 – 2027
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Swope Health Central | Kansas City | Missouri | 64130 | Recruiting |
| University of Kansas Medical Center | Kansas City | Missouri | 64130 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05703672, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 28, 2025 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05703672 live on ClinicalTrials.gov.